Educate Hep C Patients About Potential Glucose Effects of Antivirals

Health Canada is warning about possible blood glucose changes in patients who take certain hep C meds.

The concern is with newer "direct-acting antivirals"...such as Zepatier, Maviret, and Epclusa.

There are reports of these meds linked to low or high blood glucose levels and new-onset diabetes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote